South Africa’s New COVID-19 Antigen Test is Able to Detect Omicron 12/01/2022 Kerry Cullinan CAPE TOWN – A locally produced COVID-19 rapid antigen test that was recently approved by South Africa’s medicines regulator is able to detect Omicron, according to its developer. This follows some controversy about whether antigen tests were able to detect Omicron, and suggestions that throat swabs might be more effective than nasal swabs as Omicron […] Continue reading -> India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> South Africa Dumps COVID-19 Restrictions as Economic Need Overshadows ‘Mild’ Omicron 07/01/2022 Kerry Cullinan CAPE TOWN – Shortly before New Year’s eve, the South African government lifted the country’s curfew and allowed indoor gatherings of up to 1000 people – despite the prevalence of the highly infectious Omicron variant. The Cabinet-level decision was taken after considering “the trajectory of the pandemic, the levels of vaccination in the country and […] Continue reading -> COVID-19 Vaccination Has Slight But ‘Clinically Insignificant’ Impact on Menstruation 07/01/2022 Maayan Hoffman Women who have been vaccinated against COVID-19 had a slight but not clinically significant change in the length of their menstrual cycles compared to unvaccinated women, according to a new study published by researchers from Oregon Health & Science University in Portland in Obstetrics & Gynecology. Specifically, vaccinated women experienced a less than one-day (0.71-day) […] Continue reading -> COVID-19 Could Become Endemic in Africa if 70% Vaccination Coverage is not Achieved by 2022 – Africa CDC 06/01/2022 Paul Adepoju IBADAN – COVID-19 could become “endemic” in Africa if the continent is unable to fully vaccinate 70% of its population by the end of 2022, warned Africa Centers for Disease Control Director, Dr John Nkengasong in a press conference on Thursday. An endemic disease is a disease that is always present in a certain population […] Continue reading -> The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> US FDA Approves First Two Oral Anti-COVID Treatments: Pfizer’s Paxlovid & Merck’s Molnupiravir 23/12/2021 Zachary Brennan WASHINGTON D.C. (ENDPOINTS News) – The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. The FDA decision follows upon a decision Wednesday authorizing Pfizer’s Paxlovid oral treatment, which the company said had proved to reduce the relative risk of hospitalization or death by 89% (within three days […] Continue reading -> WHO Greenlights COVID Boosters for ‘High-Risk’ Groups but Warns that Blanket Campaigns Could Harm Global Pandemic Response 22/12/2021 Elaine Ruth Fletcher WHO has issued new advice to countries supporting booster campaigns for “high risk groups” but still opposing “blanket” campaigns – or vaccines for children and adolescents under the age of 18. The latter, top WHO officials contend, could divert too many vaccines from low-and-middle member states that have low vaccination coverage rates – leading to […] Continue reading -> Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Moderna Says Existing COVID Vaccine Booster Appears Effective Against Omicron – Higher Dose Performs Even Better 20/12/2021 Elaine Ruth Fletcher In what should be reassuring news for health systems the world over, preliminary lab results suggest that Moderna’s authorised COVID booster dose of 50 µg offers 37-fold more protection against Omicron than the first two vaccine jabs after 29 days. And a 100 µg booster -comparable to the dose received in the first two shots […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
India’s Call for WTO Meeting on COVID-19 Response is ‘Premature’, Says EU 11/01/2022 Kerry Cullinan The European Union (EU) has described India’s call for an urgent meeting of the World Trade Organization (WTO) Ministerial Conference to discuss the body’s response to the COVID-19 pandemic, including a proposed waiver of relevant intellectual property protections, as “premature”. Addressing the WTO General Council informal meeting on Monday, EU Ambassador João Aguiar Machado said […] Continue reading -> South Africa Dumps COVID-19 Restrictions as Economic Need Overshadows ‘Mild’ Omicron 07/01/2022 Kerry Cullinan CAPE TOWN – Shortly before New Year’s eve, the South African government lifted the country’s curfew and allowed indoor gatherings of up to 1000 people – despite the prevalence of the highly infectious Omicron variant. The Cabinet-level decision was taken after considering “the trajectory of the pandemic, the levels of vaccination in the country and […] Continue reading -> COVID-19 Vaccination Has Slight But ‘Clinically Insignificant’ Impact on Menstruation 07/01/2022 Maayan Hoffman Women who have been vaccinated against COVID-19 had a slight but not clinically significant change in the length of their menstrual cycles compared to unvaccinated women, according to a new study published by researchers from Oregon Health & Science University in Portland in Obstetrics & Gynecology. Specifically, vaccinated women experienced a less than one-day (0.71-day) […] Continue reading -> COVID-19 Could Become Endemic in Africa if 70% Vaccination Coverage is not Achieved by 2022 – Africa CDC 06/01/2022 Paul Adepoju IBADAN – COVID-19 could become “endemic” in Africa if the continent is unable to fully vaccinate 70% of its population by the end of 2022, warned Africa Centers for Disease Control Director, Dr John Nkengasong in a press conference on Thursday. An endemic disease is a disease that is always present in a certain population […] Continue reading -> The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> US FDA Approves First Two Oral Anti-COVID Treatments: Pfizer’s Paxlovid & Merck’s Molnupiravir 23/12/2021 Zachary Brennan WASHINGTON D.C. (ENDPOINTS News) – The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. The FDA decision follows upon a decision Wednesday authorizing Pfizer’s Paxlovid oral treatment, which the company said had proved to reduce the relative risk of hospitalization or death by 89% (within three days […] Continue reading -> WHO Greenlights COVID Boosters for ‘High-Risk’ Groups but Warns that Blanket Campaigns Could Harm Global Pandemic Response 22/12/2021 Elaine Ruth Fletcher WHO has issued new advice to countries supporting booster campaigns for “high risk groups” but still opposing “blanket” campaigns – or vaccines for children and adolescents under the age of 18. The latter, top WHO officials contend, could divert too many vaccines from low-and-middle member states that have low vaccination coverage rates – leading to […] Continue reading -> Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Moderna Says Existing COVID Vaccine Booster Appears Effective Against Omicron – Higher Dose Performs Even Better 20/12/2021 Elaine Ruth Fletcher In what should be reassuring news for health systems the world over, preliminary lab results suggest that Moderna’s authorised COVID booster dose of 50 µg offers 37-fold more protection against Omicron than the first two vaccine jabs after 29 days. And a 100 µg booster -comparable to the dose received in the first two shots […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
South Africa Dumps COVID-19 Restrictions as Economic Need Overshadows ‘Mild’ Omicron 07/01/2022 Kerry Cullinan CAPE TOWN – Shortly before New Year’s eve, the South African government lifted the country’s curfew and allowed indoor gatherings of up to 1000 people – despite the prevalence of the highly infectious Omicron variant. The Cabinet-level decision was taken after considering “the trajectory of the pandemic, the levels of vaccination in the country and […] Continue reading -> COVID-19 Vaccination Has Slight But ‘Clinically Insignificant’ Impact on Menstruation 07/01/2022 Maayan Hoffman Women who have been vaccinated against COVID-19 had a slight but not clinically significant change in the length of their menstrual cycles compared to unvaccinated women, according to a new study published by researchers from Oregon Health & Science University in Portland in Obstetrics & Gynecology. Specifically, vaccinated women experienced a less than one-day (0.71-day) […] Continue reading -> COVID-19 Could Become Endemic in Africa if 70% Vaccination Coverage is not Achieved by 2022 – Africa CDC 06/01/2022 Paul Adepoju IBADAN – COVID-19 could become “endemic” in Africa if the continent is unable to fully vaccinate 70% of its population by the end of 2022, warned Africa Centers for Disease Control Director, Dr John Nkengasong in a press conference on Thursday. An endemic disease is a disease that is always present in a certain population […] Continue reading -> The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> US FDA Approves First Two Oral Anti-COVID Treatments: Pfizer’s Paxlovid & Merck’s Molnupiravir 23/12/2021 Zachary Brennan WASHINGTON D.C. (ENDPOINTS News) – The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. The FDA decision follows upon a decision Wednesday authorizing Pfizer’s Paxlovid oral treatment, which the company said had proved to reduce the relative risk of hospitalization or death by 89% (within three days […] Continue reading -> WHO Greenlights COVID Boosters for ‘High-Risk’ Groups but Warns that Blanket Campaigns Could Harm Global Pandemic Response 22/12/2021 Elaine Ruth Fletcher WHO has issued new advice to countries supporting booster campaigns for “high risk groups” but still opposing “blanket” campaigns – or vaccines for children and adolescents under the age of 18. The latter, top WHO officials contend, could divert too many vaccines from low-and-middle member states that have low vaccination coverage rates – leading to […] Continue reading -> Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Moderna Says Existing COVID Vaccine Booster Appears Effective Against Omicron – Higher Dose Performs Even Better 20/12/2021 Elaine Ruth Fletcher In what should be reassuring news for health systems the world over, preliminary lab results suggest that Moderna’s authorised COVID booster dose of 50 µg offers 37-fold more protection against Omicron than the first two vaccine jabs after 29 days. And a 100 µg booster -comparable to the dose received in the first two shots […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Vaccination Has Slight But ‘Clinically Insignificant’ Impact on Menstruation 07/01/2022 Maayan Hoffman Women who have been vaccinated against COVID-19 had a slight but not clinically significant change in the length of their menstrual cycles compared to unvaccinated women, according to a new study published by researchers from Oregon Health & Science University in Portland in Obstetrics & Gynecology. Specifically, vaccinated women experienced a less than one-day (0.71-day) […] Continue reading -> COVID-19 Could Become Endemic in Africa if 70% Vaccination Coverage is not Achieved by 2022 – Africa CDC 06/01/2022 Paul Adepoju IBADAN – COVID-19 could become “endemic” in Africa if the continent is unable to fully vaccinate 70% of its population by the end of 2022, warned Africa Centers for Disease Control Director, Dr John Nkengasong in a press conference on Thursday. An endemic disease is a disease that is always present in a certain population […] Continue reading -> The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> US FDA Approves First Two Oral Anti-COVID Treatments: Pfizer’s Paxlovid & Merck’s Molnupiravir 23/12/2021 Zachary Brennan WASHINGTON D.C. (ENDPOINTS News) – The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. The FDA decision follows upon a decision Wednesday authorizing Pfizer’s Paxlovid oral treatment, which the company said had proved to reduce the relative risk of hospitalization or death by 89% (within three days […] Continue reading -> WHO Greenlights COVID Boosters for ‘High-Risk’ Groups but Warns that Blanket Campaigns Could Harm Global Pandemic Response 22/12/2021 Elaine Ruth Fletcher WHO has issued new advice to countries supporting booster campaigns for “high risk groups” but still opposing “blanket” campaigns – or vaccines for children and adolescents under the age of 18. The latter, top WHO officials contend, could divert too many vaccines from low-and-middle member states that have low vaccination coverage rates – leading to […] Continue reading -> Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Moderna Says Existing COVID Vaccine Booster Appears Effective Against Omicron – Higher Dose Performs Even Better 20/12/2021 Elaine Ruth Fletcher In what should be reassuring news for health systems the world over, preliminary lab results suggest that Moderna’s authorised COVID booster dose of 50 µg offers 37-fold more protection against Omicron than the first two vaccine jabs after 29 days. And a 100 µg booster -comparable to the dose received in the first two shots […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Could Become Endemic in Africa if 70% Vaccination Coverage is not Achieved by 2022 – Africa CDC 06/01/2022 Paul Adepoju IBADAN – COVID-19 could become “endemic” in Africa if the continent is unable to fully vaccinate 70% of its population by the end of 2022, warned Africa Centers for Disease Control Director, Dr John Nkengasong in a press conference on Thursday. An endemic disease is a disease that is always present in a certain population […] Continue reading -> The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> US FDA Approves First Two Oral Anti-COVID Treatments: Pfizer’s Paxlovid & Merck’s Molnupiravir 23/12/2021 Zachary Brennan WASHINGTON D.C. (ENDPOINTS News) – The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. The FDA decision follows upon a decision Wednesday authorizing Pfizer’s Paxlovid oral treatment, which the company said had proved to reduce the relative risk of hospitalization or death by 89% (within three days […] Continue reading -> WHO Greenlights COVID Boosters for ‘High-Risk’ Groups but Warns that Blanket Campaigns Could Harm Global Pandemic Response 22/12/2021 Elaine Ruth Fletcher WHO has issued new advice to countries supporting booster campaigns for “high risk groups” but still opposing “blanket” campaigns – or vaccines for children and adolescents under the age of 18. The latter, top WHO officials contend, could divert too many vaccines from low-and-middle member states that have low vaccination coverage rates – leading to […] Continue reading -> Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Moderna Says Existing COVID Vaccine Booster Appears Effective Against Omicron – Higher Dose Performs Even Better 20/12/2021 Elaine Ruth Fletcher In what should be reassuring news for health systems the world over, preliminary lab results suggest that Moderna’s authorised COVID booster dose of 50 µg offers 37-fold more protection against Omicron than the first two vaccine jabs after 29 days. And a 100 µg booster -comparable to the dose received in the first two shots […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The Moonshot: Crowdsourcing to Develop the First Open-Source, Generic COVID-19 Antiviral Pill 24/12/2021 Annette von Delft, Charles Mowbray & Borna Nyaoke A global grassroots movement of scientists based on crowdsourcing ideas, expertise, and goodwill has already generated – and freely released – more than half of the known structural information on the main protease of SARS-CoV-2. Based on this, they are now on a quest for an open-source drug that can block the virus from replicating. […] Continue reading -> US FDA Approves First Two Oral Anti-COVID Treatments: Pfizer’s Paxlovid & Merck’s Molnupiravir 23/12/2021 Zachary Brennan WASHINGTON D.C. (ENDPOINTS News) – The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. The FDA decision follows upon a decision Wednesday authorizing Pfizer’s Paxlovid oral treatment, which the company said had proved to reduce the relative risk of hospitalization or death by 89% (within three days […] Continue reading -> WHO Greenlights COVID Boosters for ‘High-Risk’ Groups but Warns that Blanket Campaigns Could Harm Global Pandemic Response 22/12/2021 Elaine Ruth Fletcher WHO has issued new advice to countries supporting booster campaigns for “high risk groups” but still opposing “blanket” campaigns – or vaccines for children and adolescents under the age of 18. The latter, top WHO officials contend, could divert too many vaccines from low-and-middle member states that have low vaccination coverage rates – leading to […] Continue reading -> Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Moderna Says Existing COVID Vaccine Booster Appears Effective Against Omicron – Higher Dose Performs Even Better 20/12/2021 Elaine Ruth Fletcher In what should be reassuring news for health systems the world over, preliminary lab results suggest that Moderna’s authorised COVID booster dose of 50 µg offers 37-fold more protection against Omicron than the first two vaccine jabs after 29 days. And a 100 µg booster -comparable to the dose received in the first two shots […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US FDA Approves First Two Oral Anti-COVID Treatments: Pfizer’s Paxlovid & Merck’s Molnupiravir 23/12/2021 Zachary Brennan WASHINGTON D.C. (ENDPOINTS News) – The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. The FDA decision follows upon a decision Wednesday authorizing Pfizer’s Paxlovid oral treatment, which the company said had proved to reduce the relative risk of hospitalization or death by 89% (within three days […] Continue reading -> WHO Greenlights COVID Boosters for ‘High-Risk’ Groups but Warns that Blanket Campaigns Could Harm Global Pandemic Response 22/12/2021 Elaine Ruth Fletcher WHO has issued new advice to countries supporting booster campaigns for “high risk groups” but still opposing “blanket” campaigns – or vaccines for children and adolescents under the age of 18. The latter, top WHO officials contend, could divert too many vaccines from low-and-middle member states that have low vaccination coverage rates – leading to […] Continue reading -> Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Moderna Says Existing COVID Vaccine Booster Appears Effective Against Omicron – Higher Dose Performs Even Better 20/12/2021 Elaine Ruth Fletcher In what should be reassuring news for health systems the world over, preliminary lab results suggest that Moderna’s authorised COVID booster dose of 50 µg offers 37-fold more protection against Omicron than the first two vaccine jabs after 29 days. And a 100 µg booster -comparable to the dose received in the first two shots […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Greenlights COVID Boosters for ‘High-Risk’ Groups but Warns that Blanket Campaigns Could Harm Global Pandemic Response 22/12/2021 Elaine Ruth Fletcher WHO has issued new advice to countries supporting booster campaigns for “high risk groups” but still opposing “blanket” campaigns – or vaccines for children and adolescents under the age of 18. The latter, top WHO officials contend, could divert too many vaccines from low-and-middle member states that have low vaccination coverage rates – leading to […] Continue reading -> Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Moderna Says Existing COVID Vaccine Booster Appears Effective Against Omicron – Higher Dose Performs Even Better 20/12/2021 Elaine Ruth Fletcher In what should be reassuring news for health systems the world over, preliminary lab results suggest that Moderna’s authorised COVID booster dose of 50 µg offers 37-fold more protection against Omicron than the first two vaccine jabs after 29 days. And a 100 µg booster -comparable to the dose received in the first two shots […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media 21/12/2021 Elaine Ruth Fletcher Driven by Omicron, Africa is facing a steep wave of new COVID infections – last week reporting the fourth highest number of cases ever recorded in a single week, said WHO Director General Dr Tedros Adhanom Ghebreyesus on Monday. He was speaking at an exclusive media briefing in Geneva behind closed doors to a handful […] Continue reading -> Moderna Says Existing COVID Vaccine Booster Appears Effective Against Omicron – Higher Dose Performs Even Better 20/12/2021 Elaine Ruth Fletcher In what should be reassuring news for health systems the world over, preliminary lab results suggest that Moderna’s authorised COVID booster dose of 50 µg offers 37-fold more protection against Omicron than the first two vaccine jabs after 29 days. And a 100 µg booster -comparable to the dose received in the first two shots […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna Says Existing COVID Vaccine Booster Appears Effective Against Omicron – Higher Dose Performs Even Better 20/12/2021 Elaine Ruth Fletcher In what should be reassuring news for health systems the world over, preliminary lab results suggest that Moderna’s authorised COVID booster dose of 50 µg offers 37-fold more protection against Omicron than the first two vaccine jabs after 29 days. And a 100 µg booster -comparable to the dose received in the first two shots […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy